Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Peter Bak public
[search 0]
More
Download the App!
show episodes
 
Artwork

1
Back Bay Life Science Report

Jonathan P. Gertler and Peter Bak

icon
Unsubscribe
icon
Unsubscribe
Monthly
 
Back Bay Life Science Advisors brings you expert insights from our advisors and investment bankers in the world of BioPharma & MedTech. On this podcast, you’ll hear from our experts in life science development, commercialization, and investment banking, scientific investigators, biotech and medtech executives, physicians, and strategists who excel at guiding global life sciences companies and their investors through complex decisions. Join us for insights generated from in-depth scientific, ...
  continue reading
 
Artwork

1
Ready, Row! USA

Charlotte Pierce

icon
Unsubscribe
icon
Unsubscribe
Monthly
 
At Ready, Row! USA, we believe that rowing changes lives. We are on a mission to connect and collaborate with the rowing community – from boathouses, to masters, beginners, legends, vendors – and you! You are welcome to join us on a livestream, or jump in on the conversation thread on any of our episodes - they're "evergreen!"
  continue reading
 
Loading …
show series
 
In this DNB//Back Bay Healthcare Capital Markets podcast episode, Jim Cirenza, Head of Fixed Income and Equities at DNB, Kristoffer Braaten, Director and Head of Equity Capital Markets at DNB, and Vasilios Kofitsas, Partner and Managing Director of Investment Banking at Back Bay Life Science Advisors, review the performance of the healthcare market…
  continue reading
 
Tidsånden, ofte referert til som zeitgeist fra tysk, beskriver den rådende ånden, stemningen eller holdningen i en bestemt periode, spesielt når det gjelder ideer, verdier, kulturelle trender og sosiale normer. Denne episodebeskrivelsen er generert av KI. En podkast av Henrik Asheim, Tina Bru og Peter Frølich Hosted on Acast. See acast.com/privacy …
  continue reading
 
The topic of bispecific antibodies has been an area of interest in the pharma space for a long time now. The recent news of the notable late-stage data from Akeso and Summit’s PD-1/VEGF bispecific antibody ivonescimab to treat non-small cell lung cancer that has captured the industry writ large encouraged us to revisit the topic. To date, there hav…
  continue reading
 
MEET: Ken Gates & John Cullicott CLUB: TexasRowingCenter.org HOST: Napoleon Griffin Ken Gates has won nine (9) CRASH-B hammers, set two world records on the RowErg and won a couple Masters Nationals singles titles, about racing, training and maintaining fitness while aging. John has raced for over 40 years at the High School, College, Elite, and Ma…
  continue reading
 
Bak, Choi, Rogers - Transcript 2023 Won COPA America Mixed 4x 2022 Bronze at Beach Sprint Worlds for Mixed 4x 2021 Tokyo Paralympic PR3 Mixed 4+ Alternate Chris Bak 2021 Portugal-1x 8th BS 2022 wales 1x gold 4x bronze BS 2023 Barletta- 1x 8th BS 1x silver ENDURO 2x gold ENDURO 2024 Genoa- 1x gold Kory Rogers 4x coastal national team 2x world champi…
  continue reading
 
In this DNB//Back Bay Healthcare Capital Markets Episode, Vasilios Kofitsas, Partner and Managing Director at Back Bay Life Science Advisors speaks with Jim Cirenza and Kristoffer Braaten of DNB Bank in New York. They focus on key drivers affecting markets this year and discuss the recent news of the Fed’s decision to cut interest rates by 50-basis…
  continue reading
 
After a summer away from podcasting, Back Bay Life Science Advisors’ Dr. Pete Bak and Christian Thienel are back on the mic to discuss current market dynamics in liver disease with a focus on one of the most closely watched space in hepatology, MASH. The big news includes a rebrand from NASH (non-alcohol related steatohepatitis) to MASH (metabolic …
  continue reading
 
Irriterende Stortingsdebatter som spinner ut av kontroll, mindre Cola Zero-drikking på Stortinget, og var Ernas rabarbrasaft-video iscenesatt? Støre reagerer på «Basic bitch»-kommentar, men vet han hva det begrepet betyr? En podkast av Henrik Asheim, Tina Bru og Peter Frølich Hosted on Acast. See acast.com/privacy for more information.…
  continue reading
 
I ukens episode har vi en gjest vi aldri trodde ville stille i podkasten. Vi har et tema som er et av de aller viktigste i vår tid, men det er ikke snakk om liv eller død. Fredrik Solvang er på plass, og vi tar debatten om Debatten! En podkast av Henrik Asheim, Tina Bru og Peter Frølich Hosted on Acast. See acast.com/privacy for more information.…
  continue reading
 
In this DNB//Back Bay Healthcare Capital Markets podcast episode, learn about the key considerations, mechanics and timelines of going public on a US exchange. Topics in this podcast include: An overview of the decision-making process through execution for US-based and ex-US healthcare companies thinking about listing in the US Core considerations …
  continue reading
 
Guests: Pete Bak and Christian Thienel Length: 27 minutes In this episode of The Life Science Report, Dr. Pete Bak and Back Bay Director, Christian Thienel catch up on the area attracting the most industry interest over the past couple of years: the anti-obesity space. From big players looking to capitalize on the renewed interest in the obesity sp…
  continue reading
 
Tina tar ikke gjenvalg til Stortinget og opplever litt for mange klamme omfavnelser. Sp jobber på spreng for å ikke få vedtatt regjeringens politikk. Og må folk slutte å henge med huet i verdens mest fantastiske helsevesen som skal bli enda mer fantastisk nå? En podkast av Henrik Asheim, Tina Bru og Peter Frølich Hosted on Acast. See acast.com/priv…
  continue reading
 
Welcome to another episode with the DNB//Back Bay Partnership for Healthcare. In this episode Jonathan Gertler, Back Bay CEO and Managing Partner, is once again joined by James Cirenza, Head of Fixed Income and Equities at DNB, Kristoffer Braaten, Director of US Equity Capital Markets at DNB, and Vasilios Kofitsas, Managing Director of Investment B…
  continue reading
 
Guests: Pete Bak and Christian Thienel Length: 37 minutes With the advent of COVID-19 in 2020 and 2021, we saw a tremendous amount of interest in not only COVID vaccines, but other companies riding the tailwind and developing vaccine therapies that span across viral illness, maternal infections and bacterial infections. In this episode resident imm…
  continue reading
 
A Podcast Discussion on the Trends and Investment Activity in Radiopharmaceuticals and Psychedelics Guests: Pete Bak and Christian Thienel Length: 25 minutes Here at Back Bay we’ve seen a number of notable trends in the radiopharmaceutical and psychedelic spaces playing out over the past couple of years. Increasingly, investors have been asking our…
  continue reading
 
As we move into 2024, Back Bay’s strategic advisors summarize key product approvals from three classes and indications over this past year, including the December CRISPR and Vertex approval of Exa-cel, Biogen and Sage’s August approval of an oral treatment for women with postpartum depression and Genmab and Roche’s May approval in oncology. In this…
  continue reading
 
Alex Lynn, Youth Recreational Rowing Manager at Community Rowing Ellis Evans-Brown, Head Coach at Arlington-Belmont high school crew What is unique about rowing among all the available youth sports; when is it the right choice for young athletes? What does rowing do for kids as they grow into adulthood and prepare for college and vocations? In this…
  continue reading
 
Loading …
Listen to this show while you explore
Play